Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-01 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 100000 | $7.73 - $8.47 | $809,999 |
| 2024-05-01 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
G | Class A Common Stock | D | 25000 | $0.00 - $0.00 | $0 |
| 2024-05-02 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 21296 | $0.00 - $0.00 | $0 |
| 2024-04-30 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $7.95 - $7.95 | $90,963 |
| 2024-04-25 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 3000 | $7.67 - $7.67 | $23,020 |
| 2024-04-25 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 3000 | $1.06 - $1.06 | $3,180 |
| 2024-04-16 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $7.66 - $7.66 | $87,725 |
| 2024-04-16 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 48124 | $7.58 - $7.67 | $367,006 |
| 2024-04-16 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 75000 | $2.22 - $2.22 | $166,500 |
| 2024-04-03 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 130000 | $8.84 - $9.02 | $1,160,900 |
| 2024-04-03 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
G | Class A Common Stock | D | 25000 | $0.00 - $0.00 | $0 |
| 2024-04-03 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
| 2024-04-01 | RECURSION PHARMACEUTICALS, INC. | Li Dean Y
(Director) |
A | Class A Common Stock | A | 1267 | $0.00 - $0.00 | $0 |
| 2024-04-01 | RECURSION PHARMACEUTICALS, INC. | CHAVEZ R. MARTIN
(Director) |
A | Class A Common Stock | A | 2001 | $0.00 - $0.00 | $0 |
| 2024-04-01 | RECURSION PHARMACEUTICALS, INC. | Dar Zavain
(Director) |
A | Class A Common Stock | A | 1467 | $0.00 - $0.00 | $0 |
| 2024-04-01 | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann
(Director) |
A | Class A Common Stock | A | 1467 | $0.00 - $0.00 | $0 |
| 2024-04-02 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $8.82 - $8.82 | $100,941 |
| 2024-03-28 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 65000 | $10.10 - $10.10 | $656,500 |
| 2024-03-28 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
G | Class A Common Stock | D | 25000 | $0.00 - $0.00 | $0 |
| 2024-03-28 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
| 2024-03-21 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 8000 | $10.70 - $11.34 | $85,979 |
| 2024-03-21 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 8000 | $1.06 - $1.06 | $8,480 |
| 2024-03-19 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 20054 | $10.79 - $10.79 | $216,422 |
| 2024-03-12 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 50000 | $10.46 - $11.03 | $537,190 |
| 2024-03-12 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 75000 | $2.22 - $2.22 | $166,500 |
| 2024-03-06 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 61319 | $11.55 - $11.86 | $719,504 |
| 2024-03-06 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
M | Class A Common Stock | A | 39924 | $2.48 - $11.40 | $176,383 |
| 2024-03-06 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
G | Class A Common Stock | D | 10000 | $0.00 - $0.00 | $0 |
| 2024-03-06 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 35000 | $0.00 - $0.00 | $0 |
| 2024-03-05 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 20054 | $12.06 - $12.06 | $241,805 |
| 2024-02-22 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 8000 | $14.89 - $14.89 | $119,160 |
| 2024-02-22 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 8000 | $1.06 - $1.06 | $8,480 |
| 2024-02-20 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 20054 | $12.31 - $13.04 | $247,124 |
| 2024-02-15 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
F | Class A Common Stock | D | 7172 | $12.43 - $12.43 | $89,147 |
| 2024-02-15 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
F | Class A Common Stock | D | 5379 | $12.43 - $12.43 | $66,860 |
| 2024-02-15 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
F | Class A Common Stock | D | 11148 | $12.43 - $12.43 | $138,569 |
| 2024-02-13 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 50000 | $9.86 - $10.98 | $507,983 |
| 2024-02-13 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 75000 | $2.22 - $2.22 | $166,500 |
| 2024-02-09 | RECURSION PHARMACEUTICALS, INC. | Mauro David J
(Chief Medical Officer) |
F | Class A Common Stock | D | 1892 | $10.09 - $10.09 | $19,090 |
| 2024-02-09 | RECURSION PHARMACEUTICALS, INC. | Mauro David J
(Chief Medical Officer) |
A | Class A Common Stock | A | 55808 | $0.00 - $0.00 | $0 |
| 2024-02-09 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
F | Class A Common Stock | D | 2512 | $10.09 - $10.09 | $25,346 |
| 2024-02-09 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
A | Class A Common Stock | A | 182849 | $0.00 - $0.00 | $0 |
| 2024-02-09 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
F | Class A Common Stock | D | 3233 | $10.09 - $10.09 | $32,620 |
| 2024-02-09 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
A | Class A Common Stock | A | 344597 | $0.00 - $0.00 | $0 |
| 2024-02-07 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 48272 | $9.22 - $9.22 | $444,980 |
| 2024-02-07 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
M | Class A Common Stock | A | 31250 | $2.48 - $2.48 | $77,500 |
| 2024-02-07 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
G | Class A Common Stock | D | 10000 | $0.00 - $0.00 | $0 |
| 2024-02-07 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 10000 | $0.00 - $0.00 | $0 |
| 2024-02-06 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $9.30 - $9.30 | $106,489 |
| 2024-01-25 | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott
(President and COO) |
S | Class A Common Stock | D | 8000 | $10.35 - $10.35 | $82,761 |
| 2024-01-25 | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott
(President and COO) |
M | Class A Common Stock | A | 8000 | $1.06 - $1.06 | $8,480 |
| 2024-01-23 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 20054 | $10.58 - $10.58 | $212,083 |
| 2024-01-16 | RECURSION PHARMACEUTICALS, INC. | Virani Shafique
(Chief Business Officer) |
S | Class A Common Stock | D | 18000 | $10.93 - $10.93 | $196,740 |
| 2024-01-16 | RECURSION PHARMACEUTICALS, INC. | Virani Shafique
(Chief Business Officer) |
M | Class A Common Stock | A | 18000 | $2.22 - $2.22 | $39,960 |
| 2024-01-16 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 50000 | $10.25 - $10.45 | $517,507 |
| 2024-01-16 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 75000 | $2.22 - $2.22 | $166,500 |
| 2024-01-09 | RECURSION PHARMACEUTICALS, INC. | Li Dean Y
(Director) |
S | Class A Common Stock | D | 29000 | $13.65 - $14.03 | $396,213 |
| 2024-01-09 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 20054 | $13.21 - $13.81 | $273,201 |
| 2024-01-02 | RECURSION PHARMACEUTICALS, INC. | CHAVEZ R. MARTIN
(Director) |
A | Class A Common Stock | A | 1900 | $0.00 - $0.00 | $0 |
| 2023-12-28 | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott
(President and COO) |
S | Class A Common Stock | D | 8000 | $10.58 - $10.58 | $84,653 |
| 2023-12-28 | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott
(President and COO) |
M | Class A Common Stock | A | 8000 | $1.06 - $1.06 | $8,480 |
| 2023-12-26 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 20054 | $10.63 - $10.63 | $213,143 |
| 2023-12-15 | RECURSION PHARMACEUTICALS, INC. | Virani Shafique
(Chief Business Officer) |
S | Class A Common Stock | D | 18000 | $9.60 - $9.60 | $172,800 |
| 2023-12-15 | RECURSION PHARMACEUTICALS, INC. | Virani Shafique
(Chief Business Officer) |
M | Class A Common Stock | A | 18000 | $2.22 - $2.22 | $39,960 |
| 2023-12-12 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 50000 | $7.39 - $7.59 | $374,637 |
| 2023-12-12 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 75000 | $2.22 - $2.22 | $166,500 |
| 2023-11-16 | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott
(President and COO) |
S | Class A Common Stock | D | 3000 | $6.76 - $6.76 | $20,279 |
| 2023-11-16 | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott
(President and COO) |
M | Class A Common Stock | A | 3000 | $1.06 - $1.06 | $3,180 |
| 2023-11-15 | RECURSION PHARMACEUTICALS, INC. | Larson Tina Marriott
(President and COO) |
F | Class A Common Stock | D | 5378 | $7.18 - $7.18 | $38,614 |
| 2023-11-15 | RECURSION PHARMACEUTICALS, INC. | Virani Shafique
(Chief Business Officer) |
S | Class A Common Stock | D | 18000 | $6.51 - $6.51 | $117,180 |
| 2023-11-15 | RECURSION PHARMACEUTICALS, INC. | Virani Shafique
(Chief Business Officer) |
M | Class A Common Stock | A | 18000 | $2.22 - $2.22 | $39,960 |
| 2023-11-15 | RECURSION PHARMACEUTICALS, INC. | Virani Shafique
(Chief Business Officer) |
F | Class A Common Stock | D | 3603 | $7.18 - $7.18 | $25,869 |
| 2023-11-10 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
G | Class A Common Stock | D | 10000 | $0.00 - $0.00 | $0 |
| 2023-11-15 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
F | Class A Common Stock | D | 16913 | $7.18 - $7.18 | $121,435 |
| 2023-11-10 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 10000 | $0.00 - $0.00 | $0 |
| 2023-11-14 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 8885 | $6.32 - $6.32 | $56,150 |
| 2023-11-14 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 50000 | $6.32 - $7.62 | $340,927 |
| 2023-11-14 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 75000 | $2.22 - $2.22 | $166,500 |
| 2023-11-15 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
F | Class A Common Stock | D | 7172 | $7.18 - $7.18 | $51,494 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |